Royce & Associates’s Codexis CDXS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-19,300
Closed -$398K 945
2022
Q1
$398K Buy
+19,300
New +$400K ﹤0.01% 903
2018
Q3
Sell
-38,800
Closed -$559K 1182
2018
Q2
$559K Sell
38,800
-125,000
-76% -$1.63M ﹤0.01% 1012
2018
Q1
$1.8M Hold
163,800
0.01% 872
2017
Q4
$1.37M Hold
163,800
0.01% 915
2017
Q3
$1.09M Buy
+163,800
New +$907K 0.01% 939

Other funds holding CDXS

Royce & Associates's CDXS Position: Q2 2022 in Review

Royce & Associates sold out of Codexis (CDXS) in Q2 2022, closing a stake of 19,300 shares — an estimated $398K sold.

Royce & Associates first reported a position in CDXS in Q3 2017 and held it in 5 quarters. The position peaked at $1.8M in Q1 2018. 168 funds tracked by Wall St. Rank hold CDXS as of Q2 2022.

  • Royce & Associates reported no remaining Codexis position as of Q2 2022 after selling out during the quarter.
  • Royce & Associates sold 19,300 Codexis shares in Q2 2022, an estimated $398K.
  • Royce & Associates first reported a position in Codexis in Q3 2017 and held it in 5 quarters.
  • Royce & Associates's Codexis position peaked at $1.8M in Q1 2018.
  • 168 funds tracked by Wall St. Rank held Codexis as of Q2 2022.

Based on Royce & Associates's 13F filing for Q2 2022, filed 4 Aug 2022.